BACKGROUND AND STUDY AIM: Transjugular liver biopsy (TJLB) can be used in patients who are ineligible for percutaneous liver biopsy (PLB) with acute and chronic hepatic disease. This study aimed to evaluate the usefulness and safety of TJLB in patients who were not indicated for PLB. METHODS: Between July 2014 and February 2019, a total of 134 patients underwent liver biopsies at our institution. Among these, PLB was performed in 110 patients and TJLB in 24 patients. A retrospective comparison of clinical results in these patients was then performed. The primary endpoints of this study were the utility and safety of TJLB in patients who were not indicated for PLB. RESULTS: The procedural success rate was 100% in both groups. The clinical response rate and the effective tissue sampling rate were 100% in the TJLB group and 97% in the PLB group (p = 0.55). There was no difference in the number of portal fields examined retrospectively between the two groups. No serious adverse events were observed in either group. CONCLUSIONS: It is suggested that TJLB is useful because it can be safely performed in patients with poor general condition who are not indicated for PLB.
BACKGROUND AND STUDY AIM: Transjugular liver biopsy (TJLB) can be used in patients who are ineligible for percutaneous liver biopsy (PLB) with acute and chronic hepatic disease. This study aimed to evaluate the usefulness and safety of TJLB in patients who were not indicated for PLB. METHODS: Between July 2014 and February 2019, a total of 134 patients underwent liver biopsies at our institution. Among these, PLB was performed in 110 patients and TJLB in 24 patients. A retrospective comparison of clinical results in these patients was then performed. The primary endpoints of this study were the utility and safety of TJLB in patients who were not indicated for PLB. RESULTS: The procedural success rate was 100% in both groups. The clinical response rate and the effective tissue sampling rate were 100% in the TJLB group and 97% in the PLB group (p = 0.55). There was no difference in the number of portal fields examined retrospectively between the two groups. No serious adverse events were observed in either group. CONCLUSIONS: It is suggested that TJLB is useful because it can be safely performed in patients with poor general condition who are not indicated for PLB.
Authors: E Cholongitas; A Quaglia; D Samonakis; M Senzolo; C Triantos; D Patch; G Leandro; A P Dhillon; A K Burroughs Journal: Gut Date: 2006-04-24 Impact factor: 23.059
Authors: George Kalambokis; Pinelopi Manousou; Shusang Vibhakorn; Laura Marelli; Evangelos Cholongitas; Marco Senzolo; David Patch; Andrew K Burroughs Journal: J Hepatol Date: 2007-05-24 Impact factor: 25.083
Authors: Michel Ble; Bogdan Procopet; Rosa Miquel; Virginia Hernandez-Gea; Juan Carlos García-Pagán Journal: Clin Liver Dis Date: 2014-08-30 Impact factor: 6.126
Authors: Malgorzata Wolska-Krawczyk; Marcin Krawczyk; Marcus Katoh; Frank Grünhage; Kai Schmitt; Rainer M Bohle; Frank Lammert; Arno Buecker Journal: Abdom Imaging Date: 2013-06